A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.

Systemic amyloid light-chain (LC) amyloidosis is a disease process characterized by the pathological deposition of monoclonal LCs in tissue. All LC subtypes are capable of fibril formation although lambda chains, particularly those belonging to the lambda6 type, are overrepresented. Here, we report the thermodynamic and in vitro fibrillogenic properties of several mutants of the lambda6 protein 6aJL2 in which Pro7 and/or His8 was substituted by Ser or Pro. The H8P and H8S mutants were almost as stable as the wild-type protein and were poorly fibrillogenic. In contrast, the P7S mutation decreased the thermodynamic stability of 6aJL2 and greatly enhanced its capacity to form amyloid-like fibrils in vitro. The crystal structure of the P7S mutant showed that the substitution induced both local and long-distance effects, such as the rearrangement of the V(L) (variable region of the light chain)-V(L) interface. This mutant crystallized in two orthorhombic polymorphs, P2(1)2(1)2(1) and C222(1). In the latter, a monomer that was not arranged in the typical Bence-Jones dimer was observed for the first time. Crystal-packing analysis of the C222(1) lattice showed the establishment of intermolecular beta-beta interactions that involved the N-terminus and beta-strand B and that these could be relevant in the mechanism of LC fibril formation. Our results strongly suggest that Pro7 is a key residue in the conformation of the N-terminal sheet switch motif and, through long-distance interactions, is also critically involved in the contacts that stabilized the V(L) interface in lambda6 LCs.

[1]  B. Volkman,et al.  Altered Dimer Interface Decreases Stability in an Amyloidogenic Protein* , 2008, Journal of Biological Chemistry.

[2]  A. Cohen Primary (AL) amyloidosis. , 1993, Renal failure.

[3]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[4]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[5]  Min Zhu,et al.  Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. , 2007, Biochemistry.

[6]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[7]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Kennel,et al.  Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. , 2007, Biochemistry.

[9]  G. Cohen Align : A program to superimpose protein coordinates, accounting for insertions and deletions , 1997 .

[10]  M. Skinner AL amyloidosis: The last 30 years , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[11]  M. Ramirez-Alvarado,et al.  Structural Insights into the Role of Mutations in Amyloidogenesis* , 2008, Journal of Biological Chemistry.

[12]  S. Larson,et al.  Bence Jones KWR protein structures determined by X-ray crystallography. , 2007, Acta crystallographica. Section D, Biological crystallography.

[13]  M. Schiffer Molecular anatomy and the pathological expression of antibody light chains. , 1996, The American journal of pathology.

[14]  I. Roterman,et al.  Local and long‐range structural effects caused by the removal of the N‐terminal polypeptide fragment from immunoglobulin L chain λ , 2003, Biopolymers.

[15]  J. Richardson,et al.  Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[17]  M. Jaskólski,et al.  3D domain‐swapped human cystatin C with amyloidlike intermolecular β‐sheets , 2005, Proteins.

[18]  V. Uversky,et al.  Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.

[19]  M. Manning,et al.  Counteracting Effects of Renal Solutes on Amyloid Fibril Formation by Immunoglobulin Light Chains* , 2001, The Journal of Biological Chemistry.

[20]  J. Ghiso,et al.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits. , 1996, The American journal of pathology.

[21]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[22]  A. Solomon Clinical implications of monoclonal light chains. , 1986, Seminars in oncology.

[23]  J. Elliott,et al.  pH‐dependent fibrillogenesis of a VκIII Bence Jones protein , 1999, British journal of haematology.

[24]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 2. Incorporation of delta G degrees N-U values in a thermodynamic cycle. , 1988, Biochemistry.

[25]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[26]  A G Leslie,et al.  Biological Crystallography Integration of Macromolecular Diffraction Data , 2022 .

[27]  V. Uversky,et al.  Effect of Association State and Conformational Stability on the Kinetics of Immunoglobulin Light Chain Amyloid Fibril Formation at Physiological pH* , 2002, The Journal of Biological Chemistry.

[28]  M. Hurle,et al.  A role for destabilizing amino acid replacements in light-chain amyloidosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Becerril,et al.  The CDR1 of the human λVI light chains adopts a new canonical structure , 2005 .

[30]  M. Schiffer,et al.  Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains , 2008, Protein science : a publication of the Protein Society.

[31]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[32]  Susan Idicula-Thomas,et al.  Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: clues from inclusion body formation. , 2005, Protein engineering, design & selection : PEDS.

[33]  Mateusz Nowak,et al.  Immunoglobulin kappa light chain and its amyloidogenic mutants: A molecular dynamics study , 2004, Proteins.

[34]  Thomas E. Creighton,et al.  Protein structure : a practical approach , 1997 .

[35]  M. Schell,et al.  Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. , 1999, Biochemistry.

[36]  D. W. Bolen,et al.  Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.

[37]  J. Buxbaum Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. , 1992, Hematology/oncology clinics of North America.

[38]  C. Ionescu-Zanetti,et al.  Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.

[39]  D. A. Fernández‐Velasco,et al.  Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein: the relation between unfolding and fibrillogenesis. , 2009, Journal of molecular biology.

[40]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[41]  G N Murshudov,et al.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[42]  J. Huston,et al.  In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library. , 1995, Immunotechnology : an international journal of immunological engineering.

[43]  R. Wetzel Kinetics and thermodynamics of amyloid fibril assembly. , 2006, Accounts of chemical research.

[44]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[45]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[46]  N. Hilschmann,et al.  Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro. , 1993, Biological chemistry Hoppe-Seyler.

[47]  D. Milardi,et al.  An alternative approach in the structure-based predictions of the thermodynamics of protein unfolding. , 1997, Biophysical chemistry.

[48]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[49]  J. Wall,et al.  Towards understanding the structure-function relationship of human amyloid disease. , 2004, Current drug targets.

[50]  D. A. Fernández‐Velasco,et al.  Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains , 2008, Proteins.

[51]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[52]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.